Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herbmed Plus
- Development stage
- Phase 2
- Lead developer
- Herbal Hills
- Administration
- Oral
01
Overview
Herbmed Plus is a proprietary Ayurvedic herbal formulation developed for the treatment of renal calculi (kidney stones) and the management of ureteral stent-related discomfort. The preparation is intended to reduce the size and surface area of stones, promote their expulsion, and prevent recurrence. It also exhibits anti-inflammatory and analgesic properties, which help alleviate pain and reduce the requirement for conventional analgesics. Herbmed Plus has been evaluated in Phase II clinical trials sponsored by the AMAI Charitable Trust, where it was compared against placebo and standard anti-cholinergic medications.
- Brand names
- Herbmed Plus
- Other names
- Herbmed Plus
Beyond the preview
Go deeper on Herbmed Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Herbmed Plus.